BeiGene Ltd (BGNE)
148.56
-5.70
(-3.69%)
USD |
NASDAQ |
May 31, 16:00
148.78
+0.22
(+0.15%)
Pre-Market: 20:00
BeiGene Profit Margin (Quarterly): -33.41% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -33.41% |
December 31, 2023 | -57.94% |
September 30, 2023 | 27.57% |
June 30, 2023 | -64.03% |
March 31, 2023 | -77.81% |
December 31, 2022 | -117.2% |
September 30, 2022 | -143.8% |
June 30, 2022 | -165.6% |
March 31, 2022 | -141.9% |
December 31, 2021 | -276.0% |
September 30, 2021 | -212.2% |
June 30, 2021 | -320.2% |
March 31, 2021 | 10.98% |
December 31, 2020 | -500.3% |
September 30, 2020 | -466.9% |
June 30, 2020 | -510.7% |
March 31, 2020 | -698.7% |
December 31, 2019 | -682.1% |
September 30, 2019 | -613.0% |
June 30, 2019 | -35.16% |
Date | Value |
---|---|
March 31, 2019 | -215.4% |
December 31, 2018 | -457.2% |
September 30, 2018 | -265.7% |
June 30, 2018 | -297.1% |
March 31, 2018 | -321.4% |
December 31, 2017 | -546.5% |
September 30, 2017 | 53.31% |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | -6.14K% |
March 31, 2016 | -3.25K% |
December 31, 2015 | -582.6% |
September 30, 2015 | -1.01K% |
June 30, 2015 | -408.8% |
March 31, 2015 | -740.5% |
December 31, 2014 | -271.6% |
September 30, 2014 | -150.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-698.7%
Minimum
Mar 2020
27.57%
Maximum
Sep 2023
-253.9%
Average
-154.7%
Median
Profit Margin (Quarterly) Benchmarks
Theravance Biopharma Inc | -80.42% |
LumiraDx Ltd | -236.8% |
Dr Reddy's Laboratories Ltd | 18.49% |
Jazz Pharmaceuticals PLC | -1.62% |
Zai Lab Ltd | -61.36% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -21.07% |
Return on Assets | -13.67% |
Return on Invested Capital | -17.69% |
Gross Profit Margin (Quarterly) | 83.38% |
Operating Margin (Quarterly) | -34.77% |
Return on Net Operating Assets | -34.65% |